Matt Yordy is senior vice president, Strategy and Business Development, McKesson Corporation. Yordy also serves as a member of the McKesson Specialty Health Leadership Team.Prior to joining McKesson, Yordy ran his own strategic advisory firm and assisted clients with strategic planning activities, M&A analysis and execution, and executive team alignment.For 12 years prior to that, Yordy was senior vice president and chief strategy officer for Prime Therapeutics. During his tenure at Prime, the company grew from 150 employees to more than 3,500, and from $100 million in top line revenue to more than $12.0 billion. In his role, Yordy led Corporate Strategy, Business Development, M&A, Sales, Marketing, Product Development and Government Affairs.Yordy earned his MBA from Queens University in Charlotte, North Carolina, and has completed the M&A executive education program at The Wharton School at The University of Pennsylvania. He earned a bachelor’s degree in Economics and Finance at Creighton University in Omaha, Nebraska. He is currently based in The Woodlands, Texas.